PHRANQ D. TAMBURRI, NMD Throughout the world, news of exciting advancements in prostate cancer (CaP) – which I hinted at last year – has been limited due to the coronavirus. Nevertheless, there have […]
Docere Phranq D. Tamburri, NMD Over the past decade, as has been documented in my previous NDNR articles, my practice
Student Scholarship – First Place Case Study Roxanne Ahmadpour Jennifer Brusewitz, ND Functional gastrointestinal (GI) disorders are physical manifestations that
Docere Phranq D. Tamburri, NMD This article will: Explain why prostate cancer (CaP) treatment objectives are more important than specific
Lyn Patrick, ND In August 2012, the Centers for Disease Control and Prevention1 published final recommendations for hepatitis C screening
Phranq D. Tamburri, NMD No topic in the current landscape of urology has been so discussed and wrangled as the
Eric Yarnell, ND Prostate-specific antigen (PSA) is a protease produced by prostate cells to liquefy the semen. Though it is
Phranq D. Tamburri, NMD This article explores two main areas in treating prostate disease. First, the current situation regarding prostate
